Kent Furnish, Plaintiff-Appellant, v. SVI Systems, Incorporated, Defendant-Appellee.
No. 99-2431
United States Court of Appeals For the Seventh Circuit
Argued September 10, 2001--Decided October 22, 2001
Before Posner, Kanne, and Evans, Circuit Judges.
Appeal from the United States District Court for the Central District of Illinois. No. 96 C 1581--Joe B. McDade, Chief Judge.
I. History
Defendant SVI Systems (“SVI“), based in Peoria, Illinois, provides real time video services to hotels and motels in the eastern and midwestern portions of the United States. SVI salespeople enter into contracts with individual hotels and motels, and then SVI technicians go on-site to install the equipment in the facility. After installation, SVI monitors the equipment from its offices in Peoria.
On August 29, 1995, gastroenterologist Dr. Ben Dolin diagnosed plaintiff with chronic Hepatitis B. Dr. Dolin later took a biopsy of plaintiff‘s liver, and, on January 9, 1996, a pathologist analyzed the tissue sample and concluded that plaintiff suffered from chronic Hepatitis B and severe septal fibrosis suggestive of liver disease. Hepatitis B damages liver cells so that there are fewer cells to perform the liver‘s detoxification function and to produce glucose. Fibrosis is liver scarring, which affects the liver‘s ability to perform its blood filtering function.
On January 26, 1996, plaintiff began treating his disease with the drug Interferon. The Interferon treatment caused plaintiff to experience flu-like symptoms such as fatigue, nausea, and achiness. By May, 1996, Dr. Dolin concluded that the Interferon treatment was not working and referred plaintiff to the University of Iowa Medical School for treatment. On June 17, 1996, plaintiff was seen by Dr. Douglas LaBreque, a professor of Internal Medicine and Director of Liver Services at the University of Iowa Medical School. Blood tests taken by Dr. LaBreque that day detected liver enzymes that indicated that plaintiff‘s liver was functioning normally. Dr. LaBreque testified at his deposition that as of June, 1996, plaintiff‘s liver functioning was “adequate,” meaning that he had enough normal liver cells “to do the job.” Dr. LaBreque placed plaintiff on an experimental drug called Lamivudae, and
In January, 1996, soon after he was diagnosed with Hepatitis B, plaintiff met with his new supervisor, Don Decker, and with Beth Salmon, SVI‘s president. Plaintiff informed them about his disease and warned them that in the coming months, he may suffer from a failure to sleep, nausea, mood swings, and irritability because of the disease and its treatment. He also explained to them that these same symptoms may require him to miss some work. Soon thereafter, plaintiff‘s wife, a registered nurse, also informed Salmon that plaintiff may need to miss some work in the future because of his flu-like symptoms and because of doctor appointments. She also told Salmon that she was worried that plaintiff would be unable to travel. At his deposition, however, Dr. LaBreque testified that plaintiff was not under any work or travel restrictions.
In March, 1996, after plaintiff told his supervisor that his health prevented him from traveling to locations far from Peoria in order to complete installations, Decker responded that plaintiff was to do whatever was necessary to complete the jobs. That same month, Decker reprimanded plaintiff for missing a scheduled meeting with an installer. Plaintiff claimed that he missed the meeting because he had vomited and had to go home to rest.
When Decker became plaintiff‘s supervisor in January, 1996, SVI had hundreds of outstanding installations that needed completion. In order to complete these installations, Decker wanted the installers to complete twelve installations per week. By June 1, 1996, plaintiff had fallen behind on these installations, and, by that time, SVI had contracted with hundreds of additional properties for installations. Because he had fallen behind on these installations, on July 1, 1996, plaintiff was directed to focus solely on pre-installation technical work and was relieved of his duties with respect to installations.
Plaintiff was fired on July 25, 1996. Decker prepared a memorandum memorializing the reasons for plaintiff‘s discharge, stating that he was being
On December 18, 1996, plaintiff brought a lawsuit alleging, inter alia, discrimination on the basis of a disability.1 He brought suit under the ADA, which prohibits discrimination in employment of a “qualified individual with a disability.”
II. Analysis
A. Standard of Review
We review a grant of summary judgment de novo, viewing all of the facts, and drawing all reasonable inferences therefrom, in favor of the nonmoving party. See Cent. States, Southeast and Southwest Areas Pension Fund v. White, 258 F.3d 636, 639 (7th Cir. 2001). Summary judgment should be granted if the “pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving
B. Was Plaintiff a “Qualified Individual with a Disability?”
The ADA prohibits an employer from “discriminat[ing] against a qualified individual with a disability because of the disability.”
The Supreme Court has devised a three-part test for determining whether a plaintiff is “disabled” under
Plaintiff suffers from cirrhosis caused by chronic Hepatitis B. Dr. Dolin testified at his deposition that cirrhosis “is significant scarring [of the liver] to the point where it compromises the liver.” This reduced liver functioning affects the ability of plaintiff‘s body to eliminate toxins and maintain appropriate glucose levels.
Plaintiff‘s ADA claim fails, however, because his alleged major life activity is not a major life activity under the ADA. On appeal, plaintiff alleges that his Hepatitis B impairment affected the major life activity of “liver function.” The Equal Employment Opportunity Commission Regulations interpreting the ADA (“ADA regulations“) describe major life activities as activities such as “caring for oneself, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, and working.”
The Supreme Court‘s decision in Bragdon, 524 U.S. at 637-38, clarifies what type of activities constitute major life activities under the ADA. In that case, the plaintiff, who had the HIV virus, brought an ADA claim against a dentist who refused to treat her in his office. See id. at 629. The plaintiff claimed that her HIV infection substantially limited the major life activity of reproduction. See id. at 637. The Court concluded that reproduction was a major life activity for ADA purposes. See id. at 638. Citing regulations that were nearly identical to the ADA regulations, the Court reasoned that reproduction was a major life activity because it was “central to the life process.” Id. In other words, “the touchstone for determining an activity‘s inclusion under the statutory rubric is its significance.” Id. (citation omitted).
This court has interpreted Bragdon to mean that a major life activity is something that is “integral to one‘s daily existence.” Lawson, 245 F.3d at 923. Using this standard, this court has
Plaintiff‘s argument misses that essential link. He argues that Hepatitis B should be a disability because it is a chronic illness that affects the functioning of a major organ. However, under the ADA, even a serious illness such as Hepatitis B does not equate with a disability. Only when the impact of the illness substantially limits a major life activity--such as working--is an individual considered disabled within the meaning of the ADA.
Plaintiff, however, has never asserted “working“--or any other activity--as being substantially limited. Liver function is the only alleged “major life activity” that this court can consider, as it was the only one articulated by plaintiff. See Bragdon, 524 U.S. at 638. In that case, the Court noted that a party who had the HIV virus could have alleged that the infection imposed substantial limitations on a number of major life activities other than
Even if liver function served as a major life activity under the ADA, plaintiff‘s claim would fail because he cannot prove that his disease “substantially limited” the functioning of his liver. The ADA regulations state that a person is “substantially limited” by an impairment if that person is either “‘[u]nable to perform a major life activity’ or is ‘significantly restricted as to the condition, manner or duration’ under which the individual can perform the major life activity as compared to the average person in the general population.” Skorup, 153 F.3d at 514 (quoting
The record reveals that plaintiff‘s liver function was not substantially limited. To summarize plaintiff‘s relevant medical history, Dr. Dolin
Looking at the three factors--the nature and severity of the impairment, its duration, and the long-term effects--it is clear that plaintiff‘s disease did not substantially limit his liver function. In evaluating the effect of plaintiff‘s impairment on his liver function, “we must examine the plaintiff‘s condition as it exist[ed] after corrective or mitigating measures used to combat the impairment” were taken. Lawson, 245 F.3d at 924. At the time of plaintiff‘s termination, Dr. LaBreque considered plaintiff‘s liver function to be “adequate” enough “to do the job.” As Dr. LaBreque stated in his deposition: “if you‘ve got cirrhosis, [plaintiff is] doing as well as you can do with cirrhosis.” The duration of plaintiff‘s impairment also militates against finding that his liver function was substantially impaired. After treating his disease with Lamivudae, plaintiff‘s liver disease became dormant. Finally, plaintiff may not suffer long-term effects from his liver disease. Dr. Dolin testified that in June, 1997, plaintiff‘s liver function tests were “absolutely normal” with “no evidence of liver failure.” Therefore, plaintiff‘s Hepatitis B and cirrhosis did not substantially limit his liver function.
III. Conclusion
Because of the foregoing, we AFFIRM the
